Skip to main content
Bafna Pharmaceuticals Limited logo

Bafna Pharmaceuticals Limited — Investor Relations & Filings

Ticker · BAFNAPH ISIN · INE878I01022 LEI · 984500D03E2C7Y5EE587 BSE.NS Manufacturing
Open in API
Filings indexed 249 across all filing types
Latest filing 2023-06-28 Regulatory Filings
Country IN India
Listing BSE.NS BAFNAPH

About Bafna Pharmaceuticals Limited

http://bafnapharma.com/

Bafna Pharmaceuticals Limited specializes in the development, manufacture, and marketing of a diverse range of pharmaceutical formulations. The company operates manufacturing facilities certified by WHO-GMP standards, ensuring high-quality production of finished dosage forms including tablets, capsules, syrups, and suspensions. Its therapeutic portfolio spans multiple categories such as anti-infectives, analgesics, cardiovascular, gastrointestinal, and vitamins. The organization serves both domestic and international markets, with a significant presence in emerging regions across Africa, Southeast Asia, and the CIS. In addition to its proprietary product line, the company provides comprehensive contract manufacturing and formulation development services, leveraging its technical expertise and regulatory compliance to meet global healthcare requirements.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter from Bafna Pharmaceuticals Limited addressed to stock exchanges regarding the closure of the "Trading Window" for insiders and connected persons. It references the upcoming declaration of audited financial results for the quarter ending June 30, 2023, but does not contain any financial data or the results themselves. The document is short (2310 characters) and serves as an announcement related to insider trading restrictions ahead of financial results disclosure. It is not a financial report, earnings release, or any detailed report but rather a regulatory announcement about trading restrictions. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2023-06-28 English
Outcome of Board Meeting
Board/Management Information Classification · 100% confidence The document is a formal announcement from Bafna Pharmaceuticals Limited regarding the outcome of a Board Meeting held on June 26, 2023. It details the appointment of three new directors with their roles, terms, and brief profiles. The document is addressed to stock exchanges and includes disclosures pursuant to regulatory requirements. There is no financial data, earnings information, or report publication mentioned. The content focuses solely on changes in the company's board of directors. Therefore, this document fits the category of Board/Management Information (MANG). The document length (7546 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2023-06-27 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2023-06-23 English
Board Meeting — BAFNA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 26-Jun-2023 to consider Other business.
Regulatory Filings
2023-06-23 English
Board Meeting — Other business matters
Board/Management Information Classification · 100% confidence The document is a notice of a Board Meeting scheduled to consider and approve the appointment of new directors. It is addressed to stock exchanges and signed by the Company Secretary. The content focuses on management changes and appointments, which aligns with announcements related to board or senior management changes. The document length is short (1989 characters) and does not contain financial data or detailed reports. Therefore, it is not an Annual Report, Interim Report, or any financial disclosure. It is not a report publication announcement either, but a direct announcement of board changes. Hence, the appropriate classification is Board/Management Information (MANG).
2023-06-23 English
Annual Secretarial Compliance Report
Regulatory Filings
2023-05-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.